Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vera Therapeutics Inc Cl A (VERA)

Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,897,027
  • Shares Outstanding, K 63,323
  • Annual Sales, $ 0 K
  • Annual Income, $ -95,990 K
  • EBIT $ -145 M
  • EBITDA $ -149 M
  • 60-Month Beta 1.03
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.74

Options Overview Details

View History
  • Implied Volatility 53.95% ( +0.38%)
  • Historical Volatility 70.00%
  • IV Percentile 2%
  • IV Rank 2.54%
  • IV High 148.96% on 11/30/23
  • IV Low 51.47% on 11/14/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 10
  • Volume Avg (30-Day) 185
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 7,645
  • Open Int (30-Day) 8,231

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.82
  • Number of Estimates 6
  • High Estimate -0.59
  • Low Estimate -0.90
  • Prior Year -0.58
  • Growth Rate Est. (year over year) -41.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.22 +16.65%
on 10/23/24
51.61 -11.35%
on 11/13/24
+4.59 (+11.15%)
since 10/18/24
3-Month
35.30 +29.60%
on 09/12/24
51.61 -11.35%
on 11/13/24
+5.54 (+13.78%)
since 08/20/24
52-Week
12.28 +272.56%
on 11/27/23
51.61 -11.35%
on 11/13/24
+32.25 (+238.89%)
since 11/20/23

Most Recent Stories

More News
Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer

VERA : 46.53 (+1.70%)
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VERA : 46.53 (+1.70%)
Vera Therapeutics Partners with University of Michigan on the NEPTUNE Match Project and PIONEER Study

VERA : 46.53 (+1.70%)
Vera Therapeutics to Participate at Upcoming Investor Conferences

VERA : 46.53 (+1.70%)
Vera Therapeutics to Participate at Upcoming Investor Conferences

VERA : 46.53 (+1.70%)
Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

VERA : 46.53 (+1.70%)
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock

VERA : 46.53 (+1.70%)
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

VERA : 46.53 (+1.70%)
Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

VERA : 46.53 (+1.70%)
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VERA : 46.53 (+1.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Vera Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

See More

Key Turning Points

3rd Resistance Point 47.97
2nd Resistance Point 47.22
1st Resistance Point 46.48
Last Price 46.53
1st Support Level 44.99
2nd Support Level 44.24
3rd Support Level 43.50

See More

52-Week High 51.61
Last Price 46.53
Fibonacci 61.8% 36.59
Fibonacci 50% 31.94
Fibonacci 38.2% 27.30
52-Week Low 12.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar